MONA Mansour abugalal

Led multidisciplinary oncology teams discussion for complex oncology cases with cross-specialty coordination.
Managed inpatient and outpatient oncology cases with up-to-date treatment planning, improving patient outcome.
Assists the Consultant in providing required patient care and management in the field of Medical Oncology.
Provides consultation (inpatient, and emergency room) upon request and responds in a timely manner within the prescribed timeframe as outlined in the Hospital’s policy.
Conducts daily morning rounds to identify patients ready for discharge.
Ensures that discharge orders are written 24 hours prior to discharge.

Expertly diagnose and manage a broad spectrum of solid tumors and hematologic malignancies, ensuring precision in staging and therapeutic selection. Individualized treatment plans, including the latest generation of Immunotherapy, Targeted Therapy, and Hormonal Therapy, tailored to patient-specific molecular profiles. Monitor treatment responses and manage complex therapy-related toxicities, while integrating supportive and palliative care to enhance patient quality of life. Management of critical oncologic emergencies, including Febrile Neutropenia, Spinal Cord Compression, and Tumor Lysis Syndrome, ensuring rapid stabilization and intervention. Actively contribute to Multidisciplinary Tumor Board (MDT) meetings, collaborating with surgeons, radiologists, and pathologists to reach consensus on complex cases.

Supervised Oncology Infusion Unit, ensuring safe administration of chemotherapy, targeted therapy, and immunotherapy.
Coordinated referral pathways through the Outreach program between Hafar Albatin and King Fahd Specialist Hospital (KFSH-Dammam).
Actively participated in Multidisciplinary Team (MDT) meetings and Virtual Saudi Tumor Boards to optimize individualized treatment plans.
Assists the Consultant in providing required patient care and management in the field of Medical Oncology.
Provides consultation (inpatient, and emergency room) upon request and responds in a timely manner within the prescribed time frame as outlined in the Hospital’s policy.
Implemented Oncology Survivorship protocols, focusing on long-term side effect and early detection of recurrence.

Committed to patient safety, multidisciplinary teamwork, and providing high-quality palliative and survivorship care.
Supervised Oncology Infusion Unit, ensuring safe administration of chemotherapy, targeted therapy, and immunotherapy.
Provides consultation (inpatient, and emergency room) upon request and responds in a timely manner within the prescribed timeframe as outlined in the Hospital’s policy.
Implemented Oncology Survivorship protocols, focusing on long-term side effect and early detection of recurrence.

Supervised Oncology Infusion Unit, ensuring safe administration of chemotherapy, targeted therapy, and immunotherapy.
Provides consultation (inpatient, and emergency room) upon request and responds in a timely manner within the prescribed timeframe as outlined in the Hospital’s policy.
Implemented Oncology Survivorship protocols, focusing on long-term side effect and early detection of recurrence.

Supervised Oncology Infusion Unit, ensuring safe administration of chemotherapy, targeted therapy, and immunotherapy. Coordinated referral pathways through the Outreach program between Hafar Albatin and King Fahad Specialist Hospital (KFSH-Dammam). Actively participated in Multidisciplinary Team (MDT) meetings and Virtual Saudi Tumour Boards to optimize individualized treatment plans. Implemented Oncology Survivorship protocols, focusing on long-term side effect and early detection of recurrence.

Committed to patient safety, multidisciplinary teamwork, and providing high-quality palliative and survivorship care.Diagnose and manage solid tumors and/or hematologic malignancies according to specialty scope.Manage oncologic emergencies such as febrile neutropenia, spinal cord compression, tumor lysis syndrome, and hypercalcemia of malignancy.

individualized treatment plans, including the latest generation of Immunotherapy, Targeted Therapy, and Hormonal Therapy, tailored to patient-specific molecular profiles. • monitor treatment responses and manage complex therapy-related toxicities, while integrating supportive and palliative care to enhance patient quality of life. • management of critical oncologic emergencies, including Febrile Neutropenia, Spinal Cord Compression, and Tumor Lysis Syndrome, ensuring rapid stabilization and intervention.